Banned Drugs - Drugs Banned in India - List of Banned Drugs - References

References:

1. Adverse drug reactions - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297296/)
2. A study on drug safety monitoring program in India - (https://www.ijpsonline.com/articles/a-study-on-drug-safety-monitoring-program-in-india.html)
3. Rise and fall of anti-obesity drugs - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083904/)
4. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization - (https://pubmed.ncbi.nlm.nih.gov/17605893/)
5. Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838750/)
6. Ban on Manufacture for sale and Distribution of Rosiglitazone and their formulations for human use - (https://www.dfda.goa.gov.in/media-1/158-ban-on-manufacture-for-sale-and-distribution-of-rosiglitazone-and-their-formulations-for-human-use)
7. Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819028/)
8. Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364982/)
9. Gatifloxacin Ophthalmic Solution for Treatment of Bacterial Conjunctivitis: Safety, Efficacy and Patient Perspective - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619660/)
10. Prohibition of 328 Fixed Dose Combinations by the Central Government vide Gazette notification nos. S.O. 4379 (E) to S.O. 4706(E) - (https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTk1Mg==)
11. List of Drugs Prohibited for Manufacture and Sale Through Gazette Notifications Under Section 26a of Drugs & Cosmetics Act 1940 by the Ministry of Health and Family Welfare With Their Present Status As On 22.11.2021. - (https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=ODE5Mg==)
12. Substandard (contaminated) paediatric medicines - (https://www.who.int/news/item/05-10-2022-medical-product-alert-n-6-2022-substandard-(contaminated)-paediatric-medicines)
13. Oxyphenbutazone - (https://pubchem.ncbi.nlm.nih.gov/compound/Oxyphenbutazone)
14. Use of nimesulide in Indian children must be stopped - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125612/)
15. Propoxyphene and the Risk of Out-of-Hospital Death - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694329/)
16. Furazolidone therapy for Helicobacter pylori: Is it effective and safe? - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670425/)
17. Detection, accumulation and distribution of nitrofuran residues in egg yolk, albumen and shell - (https://pubmed.ncbi.nlm.nih.gov/17164214/)
18. Anabolic Steroids - (https://www.ncbi.nlm.nih.gov/books/NBK482418/)
19. Discontinuation of thioridazine - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1124456/)
20. Pergolide - (https://pubchem.ncbi.nlm.nih.gov/compound/Pergolide)
21. Pemoline - (https://pubchem.ncbi.nlm.nih.gov/compound/Pemoline)
22. Withdrawal of cerivastatin from the world market - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524/)
23. Case series on a diversity of illicit weight-reducing agents: from the well known to the unexpected - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040546/)
24. Final report on the safety assessment of human placental protein, hydrolyzed human placental protein, human placental enzymes, human placental lipids, human umbilical extract, placental protein, hydrolyzed placental protein, placental enzymes, placental lipids, and umbilical extract - (https://pubmed.ncbi.nlm.nih.gov/12042062/)

Author: Dr. Simi Paknikar

Editor: Dr. Janani Priya / Dr. Hena Mariam

Technically Checked by: Lingaraj